Evidence map›Paper›PMID 35549806›Full record

ArticleBioengineered2022

Circular_0086414 induces SPARC like 1 (

Qingfeng Jiang, Haoran Wang, Dongfeng Yuan, Xin Qian, Xiaochao Ma, Ming Yan, Wenqun Xing

RetractedOpen access · goldAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
  5. The oncogenic functions of SPARCL1 in bladder cancer.Journal of cellular and molecular medicine · 2024
    Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qingfeng JiangDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Haoran WangDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Dongfeng YuanDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xin QianDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xiaochao MaDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Ming YanDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Wenqun XingDepartment of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China.ORCID 0000-0003-0613-6104
Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNA (circRNA) plays an important role in cancer progression. Here, we investigated the function of circ_0086414 in the malignant progression of esophageal cancer (EC). RNA expression of circ_0086414, microRNA-1290 (miR-1290), and SPARC like 1 (

Indexed as

Esophageal NeoplasmsMicroRNAsAnimalsApoptosisCadherinsCalcium-Binding ProteinsCarcinogenesisCell Line, TumorCell ProliferationExtracellular Matrix ProteinsGlycolysisHumansMiceOsteonectinRNA, CircularCadherinsCalcium-Binding ProteinsExtracellular Matrix ProteinsMicroRNAsMIRN1290 microRNA, humanOsteonectinRNA, CircularSPARCL1 protein, humancirc_0086414ECmiR-1290SPARCL1

Identifiers

PMID35549806
PMCPMC9275914
OpenAlexW4280512987

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.